Influence of Two Widely Used Solvents, Ethanol and Dimethyl Sulfoxide, on Human Sperm Parameters.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Dec 2022
Historique:
received: 28 11 2022
revised: 14 12 2022
accepted: 20 12 2022
entrez: 8 1 2023
pubmed: 9 1 2023
medline: 11 1 2023
Statut: epublish

Résumé

To study mechanisms involved in fertility, many experimental assays are conducted by incubating spermatozoa in the presence of molecules dissolved in solvents such as ethanol (EtOH) or dimethyl sulfoxide (DMSO). Although a vehicle control group is usually included in such studies, it does not allow to evaluate the intrinsic effect of the solvent on sperm parameters and its potential influence on the outcome of the experiment. In the present study, we incubated human spermatozoa for 4 h in a capacitation medium in the absence or the presence of different concentrations of EtOH and DMSO (0.1, 0.5, 1.0, and 2.0%) to assess the impact of these solvents on sperm motility, vitality, capacitation, and acrosome integrity. The presence of statistically significant relationships between increasing solvent concentrations and the investigated parameters was assessed using linear mixed models. A significant effect was observed with both solvents for total and progressive sperm motilities. We also evaluated the effect of time for these parameters and showed that the influence of the solvents was stable between 0 and 4 h, indicating an almost direct impact of the solvents. While EtOH did not influence sperm vitality and acrosome integrity, a significant effect of increasing DMSO concentrations was observed for these parameters. Finally, regarding capacitation, measured via phosphotyrosine content, although a dose-dependent effect was observed with both solvents, the statistical analysis did not allow to precisely evaluate the intensity of the effect. Based on the results obtained in the present study, and the corresponding linear mixed models, we calculated the concentration of both solvents which would result in a 5% decline in sperm parameters. For EtOH, these concentrations are 0.9, 0.7, and 0.3% for total motility, progressive motility, and capacitation, respectively, while for DMSO they are 1.5, 1.1, >2, 0.3 and >2% for total motility, progressive motility, vitality, capacitation, and acrosome integrity, respectively. We recommend using solvent concentrations below these values to dissolve molecules used to study sperm function in vitro, to limit side effects.

Identifiants

pubmed: 36613946
pii: ijms24010505
doi: 10.3390/ijms24010505
pmc: PMC9820180
pii:
doi:

Substances chimiques

Dimethyl Sulfoxide YOW8V9698H
Solvents 0
Ethanol 3K9958V90M

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fund for Scientific Research
ID : Grant Equipment UN07220F
Organisme : Fund for Medical Research in Hainaut (F.R.M.H.)
ID : CARS
Organisme : Research Institute for Biosciences (UMONS)
ID : CARS
Organisme : Research Institute for Health sciences and Technology (UMONS)
ID : CARS
Organisme : UMHAP (UMONS/Hôpital Ambroise Paré) Medical Research Centre-Scientific Inspiration for Medical Excellence in Mons
ID : doctoral grant Marie Bisconti

Références

Mol Reprod Dev. 2002 Jan;61(1):113-9
pubmed: 11774382
Biol Reprod. 2015 Dec;93(6):130
pubmed: 26490839
Gamete Res. 1987 Feb;16(2):97-107
pubmed: 3506909
Nature. 2001 Oct 11;413(6856):603-9
pubmed: 11595941
Am J Primatol. 2004 Apr;62(4):301-6
pubmed: 15085534
Reprod Fertil Dev. 2014 Jan;26(2):245-57
pubmed: 23327743
Endocrine. 2017 May;56(2):408-415
pubmed: 27422792
Anat Rec (Hoboken). 2010 Feb;293(2):298-309
pubmed: 19938110
Dev Cell. 2005 Aug;9(2):249-59
pubmed: 16054031
Pak J Biol Sci. 2009 Feb 1;12(3):239-45
pubmed: 19579952
Elife. 2020 Jan 28;9:
pubmed: 31987071
Reproduction. 2008 Nov;136(5):533-41
pubmed: 18715981
Front Cell Dev Biol. 2020 Jun 30;8:426
pubmed: 32695775
Reprod Toxicol. 2016 Dec;66:61-67
pubmed: 27686954
Mol Reprod Dev. 2011 Feb;78(2):116-23
pubmed: 21337449
Arch Androl. 1998 Sep-Oct;41(2):135-42
pubmed: 9730442
J Androl. 1991 Mar-Apr;12(2):98-103
pubmed: 2050585
Proc Soc Exp Biol Med. 1964 Oct;117:261-4
pubmed: 14223287
Sci Rep. 2015 Mar 16;5:9169
pubmed: 25772901
J Vet Med Sci. 2011 Jul;73(7):961-3
pubmed: 21441721
Andrology. 2016 Nov;4(6):990-1001
pubmed: 27389996
Anim Reprod Sci. 2009 Jan;110(1-2):1-24
pubmed: 18805659
Ecotoxicol Environ Saf. 2021 May 10;218:112281
pubmed: 33984659
PLoS Comput Biol. 2019 Jan 18;15(1):e1006691
pubmed: 30657753
Biol Reprod. 1996 Jul;55(1):80-6
pubmed: 8793062
Sci Rep. 2019 Mar 15;9(1):4641
pubmed: 30874586
Reprod Biol Endocrinol. 2017 Aug 15;15(1):65
pubmed: 28810916
Reprod Biol Endocrinol. 2021 Mar 4;19(1):39
pubmed: 33663544
Reprod Sci. 2014 May;21(5):573-81
pubmed: 24077441
Sci Rep. 2020 Jan 10;10(1):112
pubmed: 31924821
Int J Androl. 1986 Aug;9(4):259-70
pubmed: 3804467
J Reprod Infertil. 2014 Apr;15(2):62-70
pubmed: 24918078
PLoS One. 2014 Sep 19;9(9):e107447
pubmed: 25238609
Mol Hum Reprod. 2015 Mar;21(3):237-43
pubmed: 25425609
EMBO J. 2012 Apr 4;31(7):1654-65
pubmed: 22354039
Front Cell Dev Biol. 2020 Feb 26;8:61
pubmed: 32161754
J Biol Chem. 2020 Sep 18;295(38):13181-13193
pubmed: 32703901
Reprod Biol Endocrinol. 2004 Nov 09;2:75
pubmed: 15535886
FASEB J. 2014 Mar;28(3):1317-30
pubmed: 24327606
Biopreserv Biobank. 2017 Oct;15(5):422-431
pubmed: 28805449
Front Cell Dev Biol. 2021 Oct 26;9:767161
pubmed: 34765607
Anim Reprod Sci. 2015 Sep;160:1-11
pubmed: 26164525
J Androl. 2002 Mar-Apr;23(2):188-93
pubmed: 11868811
Front Cell Dev Biol. 2022 Sep 02;10:965076
pubmed: 36120567
Bio Protoc. 2020 Jul 20;10(14):e3689
pubmed: 33659359
Toxicol In Vitro. 2010 Mar;24(2):382-6
pubmed: 19896529
Cytotechnology. 2013 Oct;65(5):887-94
pubmed: 23328992
Asian J Androl. 2020 Sep-Oct;22(5):447-453
pubmed: 31621655
Mol Hum Reprod. 2016 Feb;22(2):83-92
pubmed: 26621869
Anim Reprod Sci. 2005 Jul;87(3-4):321-37
pubmed: 15911181
Toxicology. 2021 Apr 30;454:152746
pubmed: 33711355
Reprod Toxicol. 2021 Jan;99:48-55
pubmed: 33249231
J Androl. 1988 Nov-Dec;9(6):357-66
pubmed: 3215822
Mol Cell Endocrinol. 1996 Mar 1;117(1):83-93
pubmed: 8734476
Andrologia. 1999 Jan;31(1):43-7
pubmed: 9949888
Antioxidants (Basel). 2020 Jan 24;9(2):
pubmed: 31991648
Anim Reprod Sci. 2016 Jun;169:2-5
pubmed: 26936658
J Cell Physiol. 2010 Jul;224(1):71-83
pubmed: 20232304
J Clin Endocrinol Metab. 2021 May 13;106(6):e2381-e2392
pubmed: 33481994
Biol Reprod. 1982 Nov;27(4):833-40
pubmed: 7171668
Eur J Obstet Gynecol Reprod Biol. 2021 Dec;267:161-166
pubmed: 34773879
Mol Reprod Dev. 1995 Nov;42(3):318-24
pubmed: 8579846
Hum Reprod. 2000 Mar;15(3):662-6
pubmed: 10686216
Phytother Res. 2014 Nov;28(11):1735-6
pubmed: 24719313
Reprod Toxicol. 2009 Dec;28(4):542-9
pubmed: 19539023
Hum Reprod. 2014 Mar;29(3):418-28
pubmed: 24430778
Anim Reprod Sci. 2017 Feb;177:35-41
pubmed: 28011116
Hum Reprod. 2004 Aug;19(8):1826-30
pubmed: 15192063
BMC Genomics. 2016 Aug 09;17:577
pubmed: 27507061
Biol Reprod. 2000 May;62(5):1231-9
pubmed: 10775171
Mol Aspects Med. 1997;18 Suppl:S213-9
pubmed: 9266524
Hum Reprod Update. 2005 May-Jun;11(3):205-14
pubmed: 15817522
Fertil Steril. 1989 Jun;51(6):1011-8
pubmed: 2524404
Mol Reprod Dev. 1999 Apr;52(4):445-9
pubmed: 10092125
Fertil Steril. 1986 Oct;46(4):691-5
pubmed: 3758390

Auteurs

Marie Bisconti (M)

Laboratory of Cell Biology, Research Institute for Biosciences, Research Institute for Health Sciences and Technology, University of Mons, Place du Parc 23, 7000 Mons, Belgium.

Philippe Grosjean (P)

Numerical Ecology Unit, StatForU, University of Mons, Place du Parc 23, 7000 Mons, Belgium.

Vanessa Arcolia (V)

Clinique de Fertilité Régionale de Mons, CHU Ambroise Paré Hospital, Boulevard Kennedy 2, 7000 Mons, Belgium.

Jean-François Simon (JF)

Clinique de Fertilité Régionale de Mons, CHU Ambroise Paré Hospital, Boulevard Kennedy 2, 7000 Mons, Belgium.

Elise Hennebert (E)

Laboratory of Cell Biology, Research Institute for Biosciences, Research Institute for Health Sciences and Technology, University of Mons, Place du Parc 23, 7000 Mons, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH